Effect of Antisense Oligonucleotides against Cholesteryl Ester Transfer Protein on the Development of Atherosclerosis in Cholesterol-fed Rabbits*
暂无分享,去创建一个
M. Kamada | M. Sugano | N. Makino | H. Okamoto | M. Watanabe | S. Sawada | S. Otsuka | A. Mizushima
[1] S. Grundy,et al. Relation between cholesterol ester transfer protein activities and lipoprotein cholesterol in patients with hypercholesterolemia and combined hyperlipidemia. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[2] A. Tall,et al. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. , 1990, The New England journal of medicine.
[3] D. Russell,et al. Deletion in cysteine-rich region of LDL receptor impedes transport to cell surface in WHHL rabbit. , 1986, Science.
[4] S. Yamashita,et al. Molecular Defect and Atherogenicity in Cholesteryl Ester Transfer Protein Deficiency , 1994, Annals of the New York Academy of Sciences.
[5] A. Tall,et al. Plasma kinetics of cholesteryl ester transfer protein in the rabbit. Effects of dietary cholesterol. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[6] K. Marotti,et al. Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein , 1993, Nature.
[7] E. Rubin,et al. Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. , 1995, The Journal of clinical investigation.
[8] S. Yamashita,et al. Very High Density Lipoproteins Induced by Plasma Cholesteryl Ester Transfer Protein (CETP) Have a Potent Antiatherogenic Function a , 1994, Annals of the New York Academy of Sciences.
[9] T. Yanaga,et al. Effect of dietary omega-3 eicosapentaenoic acid supplements on cholesteryl ester transfer from HDL in cholesterol-fed rabbits. , 1997, Biochimica et Biophysica Acta.
[10] H. Mabuchi,et al. Deficiency of serum cholesteryl-ester transfer activity in patients with familial hyperalphalipoproteinaemia. , 1985, Atherosclerosis.
[11] T. Yanaga,et al. The effects of renin-angiotensin system inhibition on aortic cholesterol content in cholesterol-fed rabbits. , 1996, Atherosclerosis.
[12] C. Wu,et al. Enhanced resistance to nuclease degradation of nucleic acids complexed to asialoglycoprotein-polylysine carriers. , 1994, Nucleic acids research.
[13] A. Tall,et al. Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins. , 1991, The Journal of clinical investigation.
[14] C. Wu,et al. Receptor-mediated gene delivery and expression in vivo. , 1988, The Journal of biological chemistry.
[15] C. Fielding,et al. Prebeta-migrating high density lipoprotein: quantitation in normal and hyperlipidemic plasma by solid phase radioimmunoassay following electrophoretic transfer. , 1987, Journal of lipid research.
[16] Yves,et al. Monoclonal antibody inhibition of cholesteryl ester transfer protein activity in the rabbit. Effects on lipoprotein composition and high density lipoprotein cholesteryl ester metabolism. , 1989, The Journal of clinical investigation.
[17] E. Bruckert,et al. Fenofibrate reduces plasma cholesteryl ester transfer from HDL to VLDL and normalizes the atherogenic, dense LDL profile in combined hyperlipidemia. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[18] Y. Ozaki,et al. CETP is a determinant of serum LDL-cholesterol but not HDL-cholesterol in healthy Japanese. , 1996, Atherosclerosis.
[19] D. Rader,et al. Increased catabolic rate of low density lipoproteins in humans with cholesteryl ester transfer protein deficiency. , 1995, The Journal of clinical investigation.
[20] A. Tall,et al. Purification and characterization of a human plasma cholesteryl ester transfer protein. , 1987, The Journal of biological chemistry.
[21] R. Lawn,et al. Cloning and mRNA tissue distribution of rabbit cholesteryl ester transfer protein. , 1988, Journal of lipid research.
[22] A. Tall,et al. Atherogenic diet increases cholesteryl ester transfer protein messenger RNA levels in rabbit liver. , 1990, The Journal of clinical investigation.
[23] A. Tall,et al. Down-regulation of mRNA for the low density lipoprotein receptor in transgenic mice containing the gene for human cholesteryl ester transfer protein. Mechanism to explain accumulation of lipoprotein B particles. , 1993, The Journal of biological chemistry.
[24] S. Kihara,et al. Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[25] M. Sugano,et al. Changes in Plasma Lipoprotein Cholesterol Levels by Antisense Oligodeoxynucleotides against Cholesteryl Ester Transfer Protein in Cholesterol-fed Rabbits* , 1996, The Journal of Biological Chemistry.
[26] C. Wu,et al. Fate of DNA targeted to the liver by asialoglycoprotein receptor-mediated endocytosis in vivo. Prolonged persistence in cytoplasmic vesicles after partial hepatectomy. , 1993, The Journal of biological chemistry.
[27] H. Arai,et al. Purification, microheterogeneity, and stability of human lipid transfer protein. , 1989, The Journal of biological chemistry.
[28] A. Kuroiwa,et al. Suppression of Atherosclerosis in Cholesterol‐Fed Rabbits by Diltiazem Injection , 1986, Arteriosclerosis.
[29] A. Tall,et al. Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. , 1996, The Journal of clinical investigation.
[30] B. Föger,et al. Relationship of plasma cholesteryl ester transfer protein to HDL cholesterol. Studies in normotriglyceridemia and moderate hypertriglyceridemia. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[31] A. Tall,et al. Plasma cholesteryl ester transfer protein and high‐density lipoproteins: new insights from molecular genetic studies , 1995, Journal of internal medicine.
[32] A. Tall,et al. Cholesteryl ester transfer protein activity enhances plasma cholesteryl ester formation. Studies in CETP transgenic mice and human genetic CETP deficiency. , 1997, Arteriosclerosis, thrombosis, and vascular biology.